
We support biotech, biopharma, and MedTech sponsors across the full clinical development lifecycle, from early-phase strategy through regulatory submission. Our work spans contract research consulting, site management, and clinical research staffing.
Each division can function independently or as part of a fully integrated clinical development engagement.

End-to-end clinical development support for sponsors managing studies from Phase I through Phase IV. Covers clinical operations and trial management, regulatory affairs and submission support, data management and biostatistics, medical affairs and pharmacovigilance, and quality assurance across the study lifecycle.
Discuss This Service
Operational support for research sites, investigators, and participant-facing trial activities from site activation through closeout. Covers site management, investigator support, patient recruitment and retention, site-level regulatory submissions, and site performance monitoring.
Discuss This Service
Flexible clinical research staffing for sponsors and research organizations with defined project or functional needs. Covers functional service provider models, contract clinical research staffing, and dedicated teams spanning CRAs, data management specialists, regulatory writers, and pharmacovigilance officers.
Discuss This ServiceEach sector presents distinct regulatory requirements and study design considerations. Our teams are structured to address them directly.
Biotechnology & Advanced Therapies
Pharmaceuticals & Specialty Medicines
Medical Technology & Digital Health
Academic & Research Institutions
Contract Research Organizations
Clinical Trial Sites
Consulting, site management, and staffing are strongest when coordinated under a single clinical development partner rather than managed as separate vendors. We bring these divisions together so your program stays on schedule, your sites stay compliant, and your data holds up to regulatory review.
Consulting, site management, and staffing managed through one relationship, reducing handoff risk between stages.
Work conducted in line with FDA regulations and ICH E6(R2) GCP guidelines at every stage.
Support built around the realities of running a study, not a generic service list.
Clinical development is a sequential process. We provide continuity from planning through submission, reducing handoff risk and maintaining quality at every stage. Sponsors can engage us for full-program management or for targeted support at a specific stage.
Protocol development, feasibility assessment, study design, and regulatory pathway analysis for your program.
IND and IDE preparation, pre-submission meeting support, and site feasibility and activation.
On-site and remote monitoring, investigator support, data management, and ongoing safety reporting.
NDA, BLA, and 510(k) submission support, along with post-market follow-up planning.
Whether you are planning a first-in-human study, scaling a late-phase program, or need targeted support at a specific stage, our team is ready to help.
Yes. Staffing and site management support can be scoped to a specific study or engagement.
Yes. We can step in during an active study to support site operations and compliance.
Yes. Our consulting support can be engaged independently, ahead of study start-up.
Both. We support sponsors directly and provide additional site or staffing capacity to other research organizations.
Share your therapeutic area, study phase, and the support you need. We will confirm scope and propose next steps.